HSPA5 and hepatocellular carcinoma: Our findings revealed that PPI treatment significantly reduced the invasion and metastasis of drug-resistant HCC cells both in vitro and in vivo, mediated by the downregulation of GRP78 expression, which subsequently mitigated cancer cell migration and invasion (Figure 4).